Novavax COVID vaccine moves closer to full FDA approval

Novavax’s COVID-19 vaccine could soon receive full approval from the U.S. Food and Drug Administration (FDA), the company said Wednesday.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup